Viewing Study NCT07172867


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-07-21 @ 10:15 AM
Study NCT ID: NCT07172867
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
Sponsor: Halia Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
None Obesity View
Keywords: